Advances in nanotechnology-based targeted-contrast agents for computed tomography and magnetic resonance

Sci Prog. 2024 Jan-Mar;107(1):368504241228076. doi: 10.1177/00368504241228076.

Abstract

X-ray computed tomography (CT) and magnetic resonance (MR) imaging are essential tools in modern medical diagnosis and treatment. However, traditional contrast agents are inadequate in the diagnosis of various health conditions. Consequently, the development of targeted nano-contrast agents has become a crucial area of focus in the development of medical image-enhancing contrast agents. To fully understand the current development of nano-contrast agents, this review provides an overview of the preparation methods and research advancements in CT nano-contrast agents, MR nano-contrast agents, and CT/MR multimodal nano-contrast agents described in previous publications. Due to the physicochemical properties of nanomaterials, such as self-assembly and surface modifiability, these specific nano-contrast agents can greatly improve the targeting of lesions through various preparation methods and clearly highlight the distinction between lesions and normal tissues in both CT and MR. As a result, they have the potential to be used in the early stages of disease to improve diagnostic capacity and level in medical imaging.

Keywords: Contrast agents; medical imaging; multimodal imaging; nano-imaging; nanomedicine; nanoparticles.

Publication types

  • Review

MeSH terms

  • Contrast Media* / chemistry
  • Magnetic Resonance Imaging* / methods
  • Magnetic Resonance Spectroscopy
  • Nanotechnology / methods
  • Tomography, X-Ray Computed / methods

Substances

  • Contrast Media